• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wa

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Sep 7.
doi: 10.1002/jmv.27319. Online ahead of print.
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave vs the second wave


Elif Sargin Altunok[SUP] 1 [/SUP], Celal Satici[SUP] 2 [/SUP], Veysel Dinc[SUP] 3 [/SUP], Sadettin Kamat[SUP] 4 [/SUP], Mustafa Alkan[SUP] 1 [/SUP], Mustafa Asim Demirkol[SUP] 4 [/SUP], Ilkim Deniz Toprak[SUP] 5 [/SUP], Muhammed Emin Kostek[SUP] 5 [/SUP], Semih Yazla[SUP] 6 [/SUP], Sinem Nihal Esatoglu[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Due to current advances and growing experience in the management of coronavirus Disease 2019 (COVID-19), the outcome of COVID-19 patients with severe/critical illness would be expected to be better in the second wave compared to the first wave. Since our hospitalization criteria has been change in the second wave, we aimed to investigate whether a favorable outcome occurred in hospitalized COVID-19 patients with only severe/critical illness.
Methods: Among 642 laboratory confirmed hospitalized COVID-19 patients in the first wave and 1121 in the second wave, those who met World Health Organization (WHO) definitions for severe or critical illness on admission or during follow-up were surveyed. Data on demographics, comorbidities, C-reactive protein levels on admission, and outcomes were obtained from electronic hospital database. Univariate analysis was performed to compare the characteristics of patients in the first and second waves.
Results: There were 228 (35.5%) patients with severe/critical illness in the first wave and 681 (60.7%) in the second wave. Both groups were similar in terms of age, gender, and comorbidities other than chronic kidney disease. Median serum CRP levels were significantly higher in patients in the second wave compared to those in the first wave (109 mg/L (IQR: 65-157) vs 87 mg/L (IQR: 39-140); p<0.001). However, ICU admission and mortality rates were similar among the waves.
Conclusions: Even though a lower mortality rate in the second wave has been reported in previous studies including all hospitalized COVID-19 patients, we found similar demographics and outcomes among hospitalized COVID-19 patients with severe/critical illness in the first and second wave. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Turkey; demographic characteristics; mortality; the first vs second wave.
 
Back
Top Bottom